August 15, 2023
Sagicor Select Funds Limited Manufacturing & Distribution (SELECTMD) for the six months ended June 30, 2023, reported a 680% increase in Interest Income totaling $5.06 million compared to $648,000 in the corresponding period last year. Interest Income for the Second quarter had a 532% increase to close at $2.55 million compared to $404,000 for the comparable quarter of 2022.
Dividend Income amounted to $55.78 million (2022: $53.36 million), this represents an increase of 5% year over year. Consequently, net changes in fair value decreased by 144% to a loss of $121.11 million compared to a profit $278.15 million for the Six months ended June 30, 2022. The company booked net changes in fair value of $13.41 million for the Second quarter versus $40.82 million reported for the similar quarter of 2022. SELECTMD highlighted, “The drop in the value of financial assets occurred during a general downturn in investor sentiment during the first half of the year due to economic uncertainty globally and rising interest rates.”
Net investment loss closed at $60.27 million (Net investment income 2022: $332.15 million), while Net foreign currency gains/ losses and other income amounted to zero from $73,000 in 2022. As a result, total loss for the six months ended June 30, 2023, amounted to $60.27 million, relative to total revenue of $332.23 million reported in 2022.
Administration expenses for the six months ended June 30, 2023, amounted to $12.70 million, a 34% decrease relative to $19.32 million reported in 2022. Administration expenses for the Second quarter amounted to $6.00 million (2022: $10.94 million).
Total expenses for the six months ended June 30, 2023, had a 34% decrease to reach $12.70 million (2022: $19.32 million). Net loss for the Six months amounted to $72.98 million, from a net profit of $312.90 million reported in 2022. For the Second quarter, Net profit was $38.20 million (2022: $56.43 million). The Company noted, “The loss was due primarily to a net unrealized loss in fair value on financial assets of $121 million.”
Consequently, Loss Per Share for the Six months amounted to $0.02 (2022: EPS: $0.08), while Earnings Per Share for the quarter totaled $0.01 (2022: EPS: $0.01). The twelve-month trailing LPS was $0.10, and the number of shares used in these calculations was 3,816,612,000.
Notably, SELECTMD’s stock price closed the trading period on August 15, 2023, at a price of $0.56.
Balance Sheet Highlights
The company’s assets totalled $3.96 billion (2022: $4.48 billion). The decline in assets stemmed from a $493.15 million decline in Financial assets at fair value through profit or loss to value $3.73 billion.
Shareholder’s equity was $3.94 billion (2022: $4.38 billion), representing a book value per share of $1.03 (2022: $1.15).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
